Síndrome del intestino permeable: protocolo H₂ + L-glutamina

Intestinal hyperpermeability (commonly "leaky gut") refers to the alteration of tight junctions between enterocytes. A more porous mucosa allows antigenic fragments and bacterial toxins to pass into the bloodstream, fueling chronic inflammation and immune reactivity. The H₂ + L-glutamine combination is one of the most studied avenues in this field of research.

Intestinal Hyperpermeability — The Concept and Its Scientific Acceptance

Long confined to the discourse of functional medicine, intestinal hyperpermeability is now recognized in academic gastroenterology under the term increased intestinal permeability. Major reviews (Lancet 2019, Nature Reviews Gastroenterology 2020) describe it as a central pathophysiological mechanism in:

• Inflammatory Bowel Diseases (IBD)
• Irritable Bowel Syndrome (IBS), especially post-infectious
• Celiac disease and non-celiac gluten sensitivity
• Non-alcoholic fatty liver disease (NAFLD/NASH)
• Ankylosing spondylitis and certain autoimmune diseases
• Resistant depression with an inflammatory component

Mechanism of Tight Junctions

The intestinal epithelium forms a single-cell barrier between the intestinal lumen (containing 100 trillion bacteria) and the bloodstream. The seal between enterocytes is ensured by tight junctions, protein structures composed of:

• Claudin (24 isoforms, main sealing protein)
• Occludin (permeability modulator)
• ZO-1 and ZO-2 (cytoskeletal sealing proteins)
• JAM-A (junctional adhesion molecule)

Several factors alter these junctions: chronic stress (via CRF, cortisol release), intense physical exercise (especially endurance), dysbiosis, pro-inflammatory diet (ultra-processed, fast sugars, alcohol), non-steroidal anti-inflammatory drugs (NSAIDs), antibiotic therapy, digestive infections, gluten in susceptible individuals.

How to Measure Hyperpermeability

Several tests exist, with varying diagnostic value:

Zonulin remains the most accessible and clinically correlated marker. Normal value < 60 ng/mL, confirmed hyperpermeability > 80 ng/mL.

The Specific Role of L-Glutamine

L-glutamine is the most abundant amino acid in plasma. It is also the preferred fuel for enterocytes: they use it to produce ATP and synthesize tight junction proteins. In situations of stress (surgery, infection, intense exercise), L-glutamine requirements increase and can exceed endogenous production — which is why it is considered "conditionally essential."

Clinical trials (van der Hulst 1993, Wischmeyer 2008, Rao 2012) have shown that L-glutamine supplementation:

• Reduces intestinal permeability measured by the lactulose/mannitol test
• Increases the expression of ZO-1 and claudin-1 in humans
• Reduces bacterial translocation post-operatively
• Has been associated with improved symptoms in post-infectious IBS (Zhou 2018 trial)

Results observed in studies, on relevant populations — not a promise of individual results.

Validating dosage: 5 g in the morning on an empty stomach, in a glass of water, for a minimum of 8 to 12 weeks. Beyond this, continuous supplementation does not provide additional measurable benefits.

Why Research is Interested in the H₂ + L-Glutamine Combination

In preclinical models, several complementary mechanisms are being studied:

Axis 1 — Oxidative Protection of Tight Junctions

H₂ has been studied for its ability to neutralize locally produced hydroxyl radicals. In these models, this could help preserve junctional proteins (ZO-1, claudins, occludins), while L-glutamine provides the substrate for synthesizing new ones. Results observed in models — not a promise of individual results.

Axis 2 — Inflammation Pathways

Preclinical work explores the effect of H₂ on the NF-κB pathway and certain cytokines (TNF-α, IL-6), which are involved in regulating the intestinal barrier. This data is exploratory and does not constitute an established benefit of the product.

Axis 3 — Mitochondrial Support for Enterocytes

Also in models, H₂ has been studied for its role in mitochondrial function, the source of ATP for enterocytes; L-glutamine is its primary substrate. This hypothesis of complementarity still needs to be confirmed in humans.

An H₂ + L-Glutamine Ritual for 12 Weeks (Digestive Wellness)

This ritual is for well-being and is not a medical treatment. In case of persistent digestive symptoms or diagnosed pathology, consult your doctor; do not replace any treatment.

Weeks 1 to 4 — Initiation

• 500 mL HYDROGENYX Flask hydrogenated water (9,000 PPB DPD) first thing in the morning on an empty stomach
• 5 g L-glutamine powder in the same glass
• Wait 10 min before breakfast
• Strictly avoid NSAIDs, alcohol, ultra-processed foods

Weeks 5 to 8 — Consolidation

• Same morning protocol
• Add 500 mL hydrogenated water mid-afternoon (between meals)
• Add 1 multi-strain probiotic capsule (10 billion CFU, including B. longum and L. rhamnosus)
• Gradual reintroduction of fermented fibers according to tolerance

Weeks 9 to 12 — Reinforcement and Evaluation

• Maintain consolidation protocol
• Add omega-3 EPA/DHA 2 g/day with meals
• Fecal calprotectin and zonulin test (if T0 available for comparison)
• Decision: maintenance or prolongation

Maintenance (beyond week 12)

If objective clinical improvement: maintain daily H₂ (1 L/day), L-glutamine in 4-week courses every 3 months, probiotic in courses every 3 months, omega-3 continuously. Annual zonulin monitoring.

Three Common Mistakes to Avoid

Mistake 1 — Supplementing without addressing the cause. If intestinal hyperpermeability is maintained by chronic stress, an ultra-processed diet, daily alcohol, regular NSAIDs, the supplementary protocol will not work. Identifying and treating trigger factors is a priority.

Mistake 2 — Introducing too many tools at once. H₂ + L-glutamine + 5 different probiotics + 8 digestive enzymes + bone broth + zinc carnosine + turmeric. You will neither stick to the protocol nor know what works. Start simple, add gradually, evaluate.

Mistake 3 — Stopping too early. Intestinal barrier regeneration takes time. Enterocytes fully renew in 4 to 7 days, but optimizing tight junctions and mucosal immune modulation requires a minimum of 8 to 12 weeks. Many stop at 3-4 weeks thinking it's not working — that's too soon.

Limitations to Know

No large-scale human RCT has specifically tested the H₂ + L-glutamine combination on intestinal hyperpermeability. The data supporting the protocol are: (1) L-glutamine & intestinal permeability literature (several positive trials since 1993), (2) H₂ & tight junction protection literature (preclinical models Higashimura 2018, Liu 2020), (3) the clinical experience of functional doctors and our patient feedback.

This is a rational and well-tolerated protocol, but it does not have the level of evidence of an approved drug. To be positioned as an adjuvant in a holistic management approach — not as an isolated treatment for a diagnosed pathology.

Conclusion

Intestinal hyperpermeability is a studied pathophysiological mechanism, addressed in several research fields. The H₂ + L-glutamine combination is explored as a promising avenue, with accessible monitoring markers (zonulin, fecal calprotectin).

Individuals concerned by these issues should discuss them with their doctor: any approach is part of a comprehensive management plan and does not replace any treatment.